BeiGene Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 10:05:34 ET
More on BeiGene
- BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Tracking Baker Brothers Portfolio - Q3 2025 Update
- Jazz boasts of first-line Ziihera data in gastroesophageal cancers
- Seeking Alpha’s Quant Rating on BeiGene
Read the full article on Seeking Alpha
For further details see:
BeiGene Q4 2025 Earnings Preview
BeiGene Ltd.
NASDAQ: ONC
ONC Trading
2.02% G/L:
$299.05 Last:
159,174 Volume:
$292.50 Open:
ONC Latest News
February 26, 2026 06:00:00 am
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
February 20, 2026 04:03:28 pm
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model
ONC Stock Data
$39,109,836,794
83,911,918
0.1%
106
N/A
Biotechnology & Life Sciences
Healthcare
CH
Basel
